DK0841913T3 - Anvendelse af sulfaminsyrederivater, acylsulfonamider eller sulfoncarbamater til fremstilling af et lægemiddel til sænkning af lipoproteinniveauer - Google Patents

Anvendelse af sulfaminsyrederivater, acylsulfonamider eller sulfoncarbamater til fremstilling af et lægemiddel til sænkning af lipoproteinniveauer

Info

Publication number
DK0841913T3
DK0841913T3 DK96923687T DK96923687T DK0841913T3 DK 0841913 T3 DK0841913 T3 DK 0841913T3 DK 96923687 T DK96923687 T DK 96923687T DK 96923687 T DK96923687 T DK 96923687T DK 0841913 T3 DK0841913 T3 DK 0841913T3
Authority
DK
Denmark
Prior art keywords
pct
sulfonecarbamates
acylsulfonamides
medicament
manufacture
Prior art date
Application number
DK96923687T
Other languages
English (en)
Inventor
Brian Robert Krause
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0841913T3 publication Critical patent/DK0841913T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96923687T 1995-08-04 1996-07-08 Anvendelse af sulfaminsyrederivater, acylsulfonamider eller sulfoncarbamater til fremstilling af et lægemiddel til sænkning af lipoproteinniveauer DK0841913T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US303195P 1995-08-04 1995-08-04
PCT/US1996/011366 WO1997005868A1 (en) 1995-08-04 1996-07-08 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels

Publications (1)

Publication Number Publication Date
DK0841913T3 true DK0841913T3 (da) 2003-05-05

Family

ID=21703764

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96923687T DK0841913T3 (da) 1995-08-04 1996-07-08 Anvendelse af sulfaminsyrederivater, acylsulfonamider eller sulfoncarbamater til fremstilling af et lægemiddel til sænkning af lipoproteinniveauer

Country Status (27)

Country Link
US (1) US6117909A (da)
EP (1) EP0841913B1 (da)
JP (1) JPH11510184A (da)
KR (1) KR19990036127A (da)
CN (1) CN1192140A (da)
AT (1) ATE232097T1 (da)
AU (1) AU716255B2 (da)
BG (1) BG63863B1 (da)
CA (1) CA2221729A1 (da)
CZ (1) CZ26198A3 (da)
DE (1) DE69626118T2 (da)
DK (1) DK0841913T3 (da)
EA (1) EA002435B1 (da)
EE (1) EE9800037A (da)
ES (1) ES2191762T3 (da)
GE (1) GEP20012511B (da)
HR (1) HRP960341A2 (da)
HU (1) HUP9900668A3 (da)
IL (1) IL122247A0 (da)
NO (1) NO980466L (da)
NZ (1) NZ312571A (da)
PL (1) PL185943B1 (da)
PT (1) PT841913E (da)
SK (1) SK12598A3 (da)
UA (1) UA46030C2 (da)
WO (1) WO1997005868A1 (da)
ZA (1) ZA966617B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1584333A3 (en) * 1998-01-28 2009-04-29 Warner-Lambert Company LLC Use of acetylcoenzime A inhibitors for treating Alzheimer's disease
EA200100153A1 (ru) * 1998-07-21 2001-08-27 Варнер-Ламберт Компани Совместное назначение ингибиторов асат и ммр для лечения атеросклеротических поражений
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
JP2003513909A (ja) * 1999-11-05 2003-04-15 ワーナー−ランバート・カンパニー Ａｃａｔ阻害剤によるプラーク破裂の予防
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) * 2002-03-12 2005-09-06 Igt Gaming device having varying risk player selections
AR113878A1 (es) 2017-11-14 2020-06-24 Merck Sharp & Dohme Compuestos de biarilo sustituido como inhibidores de indolamina 2,3-dioxigenasa (ido)
WO2019099294A1 (en) 2017-11-14 2019-05-23 Merck Sharp & Dohme Corp. Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
WO1992007826A1 (en) * 1990-10-30 1992-05-14 Warner-Lambert Company Oxysulfonyl carbamates
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

Also Published As

Publication number Publication date
AU716255B2 (en) 2000-02-24
JPH11510184A (ja) 1999-09-07
GEP20012511B (en) 2001-08-27
AU6454196A (en) 1997-03-05
PL185943B1 (pl) 2003-09-30
US6117909A (en) 2000-09-12
EE9800037A (et) 1998-08-17
HRP960341A2 (en) 1998-02-28
PL324908A1 (en) 1998-06-22
EP0841913B1 (en) 2003-02-05
HUP9900668A3 (en) 2000-08-28
BG63863B1 (bg) 2003-04-30
ATE232097T1 (de) 2003-02-15
EA002435B1 (ru) 2002-04-25
ES2191762T3 (es) 2003-09-16
CZ26198A3 (cs) 1998-07-15
HUP9900668A2 (hu) 1999-06-28
EA199800176A1 (ru) 1998-10-29
DE69626118D1 (de) 2003-03-13
CA2221729A1 (en) 1997-02-20
DE69626118T2 (de) 2003-11-27
EP0841913A1 (en) 1998-05-20
KR19990036127A (ko) 1999-05-25
CN1192140A (zh) 1998-09-02
IL122247A0 (en) 1998-04-05
NZ312571A (en) 2000-07-28
NO980466D0 (no) 1998-02-03
SK12598A3 (en) 1999-02-11
UA46030C2 (uk) 2002-05-15
ZA966617B (en) 1997-02-18
BG102222A (en) 1998-09-30
PT841913E (pt) 2003-06-30
WO1997005868A1 (en) 1997-02-20
NO980466L (no) 1998-02-03

Similar Documents

Publication Publication Date Title
NO954564L (no) N-acylsulfaminsyre-estere (eller-tioestere), N-acylsulfonamider og N-sulfonyl-karbaminsyre-estere (eller-tioestere) som hypercholesterolemiske midler
PT863875E (pt) Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
FI943948A (fi) Heterosykliset hiilihappojohdannaiset
ATE169008T1 (de) 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
DE69607650D1 (de) 2,3,5-trimethyl-hydroxyanilid-derivative, ihre herstellung und ihre theraoeutische verwendung
ATE268752T1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
DK0841913T3 (da) Anvendelse af sulfaminsyrederivater, acylsulfonamider eller sulfoncarbamater til fremstilling af et lægemiddel til sænkning af lipoproteinniveauer
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ES2163396T3 (es) Aminas biologicamente activas.
DE69420832D1 (de) Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8
NO970340L (no) Organiske forbindelser
DE69616357D1 (de) Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
MX9709275A (es) Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.
ATE226585T1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
SE9401965D0 (sv) New compounds
ATE7298T1 (de) Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel.
DE69816832D1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
DE59806444D1 (de) Phenylketiminooxybenzylverbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE3764302D1 (de) 3-amino-dihydropyridine, ein verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.